
Al Musella
@almusella
Pres. of the Musella Foundation For Brain Tumor Research & Information, Inc. anything I say here is my own opinion and does not represent the foundation
ID: 46725191
http://virtualtrials.org 12-06-2009 19:17:53
3,3K Tweet
2,2K Followers
632 Following


GaM, the agent in @IQAI_IB's sponsored phase 1 trial & EAP, will be presented at #ASNR2025: Potent in vivo efficacy of the novel iron mimetic gallium maltolate for the treatment of primary brain tumors. Oral presentation by M. Al-Gizawiy, PhD. The American Society of Neuroradiology SNO Al Musella











